用于对增量岩芯进行采样和数字化的新工作流程

Executive Industry Relevance

Digitized increment core workflows using 3D-printed holders and high-resolution imaging systems enable rapid, reproducible sample processing for large-scale biological data generation. This approach supports high-throughput, quantitative analysis of structural features, facilitating robust hypothesis testing and cross-study comparability. The workflow is strategically positioned to enhance predictive confidence and operational efficiency in early discovery and translational research pipelines.

Strategic Applications in Biopharma R&D

Early Discovery & Target Validation

• Enables standardized sampling and digitization for quantitative structural analysis.
• Supports hypothesis-driven interrogation of biological growth patterns and responses.
• Facilitates reproducible data generation for mechanistic de-risking and target validation.

Screening & Assay Development

• Prepares validated, high-resolution digital samples for downstream image-based analysis workflows.
• Improves assay reproducibility and scalability through standardized sample handling and imaging.
• Enables reliable, quantitative measurement of structural features for screening applications.

Translational & Preclinical Research

• Provides continuity from field sampling to laboratory analysis, supporting translational biomarker discovery.
• Aligns digital outputs with preclinical model requirements for cross-study integration.
• Reduces operational bottlenecks, supporting risk-adjusted advancement decisions.

Pipeline & Workflow Integration

This workflow integrates from field sampling through digital imaging, supporting early discovery, screening, and translational research stages.

• Discovery Biology: Enables quantitative hypothesis testing and pathway clarification via digitized structural data.
• Screening: Delivers reproducible, high-resolution images suitable for automated or manual analysis.
• Analytics: Provides quantitative outputs for statistical comparison of biological conditions.
• Translational Research: Supports continuity and comparability across preclinical and translational studies.
• Enterprise Reuse: Establishes a scalable, reusable workflow for diverse biological sampling needs.

Operational & Enterprise Impact

• Scientific Value: Increases predictive confidence and reduces mechanistic ambiguity through standardized, quantitative data.
• Operational Value: Enhances reproducibility, scalability, and time efficiency in sample processing.
• Strategic Value: Improves go/no-go decision quality and capital efficiency by enabling larger, more reliable datasets.
• Portfolio Impact: Supports risk-adjusted prioritization and advancement across discovery and translational programs.

Implementation Considerations

• Requires expertise in 3D modeling, printing, and high-resolution imaging systems.
• Needs access to compatible microtomes, imaging platforms, and analytical software.
• Demands cross-team standardization for sample handling and data management.
• Adaptable to various biological sample types with consideration for model-specific requirements.
• Dependent on infrastructure for digital data storage and image analysis.

Biopharma FAQs